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Abstract
Background: Porcine circovirus type 2 (PCV2) is believed to be the primary causative agent of postweaning
multisystemic wasting syndrome (PMWS). It is supposed that capsid protein of PCV may contribute to replication
control via interaction between Cap and Rep in the nucleoplasm. In this study, we described the construction and
in vitro characterization of NLS-exchanged PCV DNA clones based on a PMWS-associated PCV2b isolate from China
to determine the role of ORF2 NLS in PCV replication.
Results: The PCV1, PCV2, PCV2-NLS1 and PCV1-NLS2 DNA clone were generated by ligating a copy of respective
genome in tandem with a partial duplication. The PCV2-NLS1 and PCV1-NLS2 DNA clone contained a chimeric
genome in which the ORF2 NLS was exchanged. The four DNA clones were all confirmed to be infectious in vitro
when transfected into PK-15 cells, as PCV capsid protein were expressed in approximately 10-20% of the transfected
cells. The in vitro growth characteristics of the DNA clones were then determined and compared. All the recovered
progeny viruses gave rise to increasing infectious titers during passages and were genetically stable by genomic
sequencing. The chimeric PCV1-NLS2 and PCV2-NLS1 viruses had the final titers of about 10
4.2 and 10
3.8 TCID50/ml,
which were significantly lower than that of PCV1 and PCV2 (10
5.6 and 10
5.0 TCID50/ml, respectively). When the ORF2
NLS exchanged, the mutant PCV2 (PCV2-NLS1) still replicated less efficiently and showed lower infectious titer than
did PCV1 mutant (PCV1-NLS2), which was consistent with the distinction between wild type PCV1 and PCV2.
Conclusions: Recovery of the chimeiric PCV1-NLS2 and PCV2-NLS1 progeny viruses indicate that the nuclear
localization signal sequence of capsid protein are functionally exchangeable between PCV1 and PCV2 with respect
to the role of nuclear importing and propagation. The findings also reveal that ORF2 NLS play an accessory role in
the replication of PCV. However, we found that ORF2 NLS was not responsible for the distinction of in vitro growth
characteristic between PCV1 and PCV2. Further studies are required to determine the in vivo viral replication and
pathogenicity of the NLS chimeric DNA clones.
Background
Porcine circovirus (PCV) is the smallest single-stranded
DNA virus replicating autonomously relying upon host
cell encoded proteins due to limited coding capacity [1].
Two types of PCV have been characterised. PCV1 was
identified as the persistent, non-cytopathic contamina-
tion of the porcine kidney cell line (PK-15) [2]. However,
PCV2 is believed to be the primary causative agent of
postweaning multisystemic wasting syndrome (PMWS)
[3,4]. The PMWS mainly affects weanling piglets at 3 to
15 weeks age, which has high morbidity and mortality
rate of up to 60% and 15% to 20%, respectively [5]. The
PMWS is characterized by generalized lymphadenopathy,
lymphocytic depletion and multinucleated giant cell for-
mation in lymph nodes, and lymphoid organ destruction,
with inflammatory lesions in multiple organs [6]. Three
* Correspondence: whfang@zju.edu.cn
† Contributed equally
2Institute of Preventive Veterinary Medicine, Zhejiang Provincial Key
Laboratory of Preventive Veterinary Medicine, Zhejiang University, 388 Yu
Hang Tang Road, Hangzhou, 310058, China
Full list of author information is available at the end of the article
Shuai et al. Virology Journal 2011, 8:341
http://www.virologyj.com/content/8/1/341
© 2011 Shuai et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.major open reading frames (ORF) are oriented in oppo-
site directions in the genome of PCV. ORF1 encodes the
replicase essential for viral DNA replication and is more
conserved between the two genotypes [7], whereas the
ORF2 is highly variable between PCV1 and PCV2 (less
than 60% homology) and encodes the only structural cap-
sid (Cap) protein that contains dominant epitopes [8,9].
Recently, an apoptosis inducing protein encoded by
ORF3 in PCV2 was identified, which was not essential for
viral replication but expedited the spread of virus [10,11].
Previous studies revealed that both the nonpathogenic
PCV1 and the pathogenic PCV2 replicated via rolling
cycle replication mechanism proposed for the Mastre-
virus genus of the Geminiviridae family and utilized com-
parable genetic elements similarly located along their
respective genomes [11-15]. Furthermore, presence of a
conserved stem-loop structure and identical essential
core element at the origin of DNA replication and simila-
rities among ORF1 in genomes of both PCVs indicated
that the loop sequences of these two viruses are function-
ally interchangeable with respect to protein synthesis and
DNA replication [16]. Taken together, the findings
showed that replication factors of PCV1 and PCV2 were
functionally exchangeable and the replication strategy
may not be the main factor determining the distinct pro-
pagation efficiency and pathogenicity of PCV1 and PCV2
[17].
Since DNA synthesis of circoviruses occurs exclusively
in the nucleus, such macromolecules can only enter the
nucleus during transient nuclear envelope breakdown or
when mediated by nuclear localization signals [18-20]. In
species of geminiviridae which are closely related to PCV,
the inactivation of nuclear localization of coat protein
result in a drastic reduction in viral ssDNA accumulation,
indicating that the coat protein may play a role in control-
ling the copy number of viral DNA [21-23]. In the case of
circoviruses, like PCV and beak and feather disease virus
(BFDV), capsid protein is expressed late in the infection
cycle and co-located in nucleoplasm together with replica-
tion protein, indicating that, beyond encapsidation, capsid
protein may contribute to replication control via interac-
tion between Cap and Rep in the nucleoplasm [23,24].
Considering the responsibility of NLS for nuclear accumu-
lation of PCV capsid protein, the information showed
above suggested a possible accessory role of the NLS in
viral replication, which probably resulted in the difference
of growth characteristics between PCV1 and PCV2. Pre-
vious studies have demonstrated that the N-terminus of
capsid protein PCV1 and PCV2 contains distinct nuclear
localization signals which are responsible for the nuclear
targeting of capsid protein during the viral life cycle
[25,26]. This study describes the construction of infectious
clones by mutagenesis on PCV ORF2 NLS and their in
vitro characteristics to determine the exchangeability of
PCV ORF2 NLS and its influence on viral replication and
propagation.
Methods
Cells and virus stocks
The PK-15 cell lines free or contaminated of PCV1 are
propagated in MEM media supplemented with 8% fetal
bovine serum (FBS, Gibco) at 37°C with 5% CO2.T h e
PCV1 and PCV2b virus stock were originated from the
contaminated PK-15 cell line and isolated from tissue
sample of a pig with naturally occurring PMWS [27].
Construction of PCV1 and PCV2 DNA clones
Non-pathogenic PCV1 and pathogenic PCV2b viral DNA
were extracted respectively from PCV1-persistently con-
taminated or PCV2-propagated PK-15 cells using the
QIAamp DNA Mini kit (QIAGEN) according to the
manufacturer’s instruction. PCV1 complete genome with
an overlapping region containing the unique Kpn I
restriction site was amplified with primers Pj3 and Pj4
(Table 1) designed based on the published sequence of
PCV1 [Genbank: NC006266]. The expected product with
1759 bp was separated by gel electrophoresis, purified,
digested by Kpn I restriction enzyme, and then cloned
into pUC-18 vector, resulting in plasmid pUC-PCV1.
Another pair of primers EcoRV-f12/EcoRI-r12 amplified
a DNA fragment of PCV1 genome (nt 621-1740) encom-
passed by EcoR V and EcoR I restriction enzymes. Both
the purified fragment and pUC-PCV1 were excised with
EcoR V and EcoR I and then joined at the restricted sites.
The resultant PCV1 DNA clone pIS-PCV1 carried a
complete genome and a duplicated fragment of PCV1
from 916 nt to 1740 nt (Figure 1).
For PCV2 DNA clone construction, a pair of primers
(Ps1 and Ps2) was designed according to PCV2 SH strain
[Genbank:DQ195679] for amplification of PCV2 com-
plete genome encompassed with the unique EcoR I
restriction site which was then digested and ligated
within pUC-18 as a recombinant plasmid pUC-PCV2. An
overlapped fragment (nt 1358-1745) of PCV2 genome
was amplified with Ps3/Ps4 containing Xba I and Kpn I
restriction region. After digestion with the enzymes, the
fragment and linearized pUC-PCV2 DNA were ligated,
resulting in the PCV2 DNA clone pIS-PCV2 which
included a full-length PCV2 genome and a duplicated
fragment from 1419 nt to 1745 nt.
Construction of chimeric PCV2-NLS1 and reciprocal PCV1-
NLS2 DNA clones
To construct PCV2-NLS1 DNA clone containing chimeric
PCV2-NLS1 genome in which NLS sequence of PCV2
ORF2 was replaced by that of PCV1, the whole recombi-
nant vector sequence without PCV2 ORF2 NLS was ampli-
fied from pUC-PCV2 with primer pair BalI-PCV2-F/
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Bal I by point mutation and BamH I. After digestion, the
linearized vector sequence was ligated with PCV1 NLS
sequence which was amplified with primers of BglII-PCV1-
F and BalI-PCV1-R and digested with Bgl II and Bal I,
resulting in vector pUC-PCV2-NLS1 containing chimeric
PCV2-NLS1 genome. The genome was then cut from
pUC-PCV2-NLS1 by EcoR I and re-cyclized. The dupli-
cated fragment (nt 1358-1745) was amplified with Ps3/Ps4
from the circular genome, digested with Xba I and Kpn I
and subcloned into pUC-PCV2-NLS1, as similar to the
construction of PCV2 DNA clone. The consequent DNA
clone pIS-PCV2-NLS1 comprised a full-length and a dupli-
cated fragment from 1419 nt to 1745 nt of the chimeric
PCV2-NLS1 genome.
To construct a reciprocal PCV1-NLS2 chimeric DNA
clone, the nuclear signal sequence of PCV1 ORF2 was
replaced by that of PCV2. Briefly, the PCV2 ORF2 NLS
sequence was amplified by primers of BamH-F/MspI-r
and ligated into recombinant plasmid sequence without
PCV1 ORF2 NLS amplified from pUC-PCV1 by ClaI-F
and BglII-r. The resultant pUC-PCV1-NLS2 plasmid
was then digested with Kpn I and the chimeric PCV1-
NLS2 genome was re-cyclized. A duplicated fragment
was amplified with EcoRV-f12/EcoRI-r12 from the cir-
cular genome, digested with EcoR V and EcoR I and
subcloned into pUC-PCV1-NLS2, resulting in the conse-
quent PCV1-NLS2 DNA clone pIS-PCV1-NLS2.
Transfection of PK-15 cells with PCV1, PCV2 and PCV2-
NLS1 DNA clones
To evaluate the in vitro infectivity of cells, the DNA clones
were purified by using Qiagen plasmid mini kit (Qiagen,
USA) and were transfected into PCV free PK-15 cells with
Lipofectamine™ 2000 (Invitrogen, USA) according to the
manufacturer’s protocols. Briefly, 80% confluent cells in
24-well plate were incubated with the mixtures of 0.8 μg
each plasmid DNA and 2.5 μl Lipofectamine™ 2000.
Mock-transfected cells with pUC-18 vector were included
as a negative control. Two days post-transfection, an
immunofluorescence assay (IFA) was performed to con-
firm the infectivity of DNA clones. Cells were fixed with a
pre-cooled 80% acetone at -20 °C for 15 minutes. After
washing with phosphate-buffered saline (PBS) containing
0.05% Tween-20 (PBS-T), the cells were incubated at 37°C
for 1 hour with 1:500-diluted polyclonal antibodies to
PCV1 or PCV2 capsid protein. The plate was washed
three times with PBS-T and incubated with the secondary
fluorescein isothiocyanate-labeled goat anti-rabbit IgG
(KPL, USA) at 37°C for another 45 minutes. After washed
and mounted, the cells were examined for expression of
viral antigen under a fluorescence microscope (Leica
DM6000B).
The genomic viral DNA distinguished from the input
plasmid DNA was monitored by primers R63 (5’-
CTTTTCTTGCTTGGCATT-3’, 46-63 nucleotide, nt)
and F894 (5’-CTGCTGGAGAACAATCC-3’, 894-910
Table 1 Primers used in construction of DNA clones
DNA clones Primer Primer Sequences (5’-3’)
c Primer location Application
PCV2 Ps1 GCGAATTCAACCTTAACCTTTCTTATTCT 1418-1446 nt PCV2 genome
DNA clone Ps2 AAGAATTCTGGCCCTGCTCCC 1407-1427 nt
a Ps3 GCTCTAGAATAACAGCACTGGAG 1356-1378 nt Duplicate
a Ps4 GAGGTACCCGTTTTCAGATATGAC 1730-1753 nt
PCV1 Pj3 ACGGTACCCGAAGGCCGATTTGAA 914-937 nt PCV1 genome
DNA clone Pj4 TAGGTACCTCCGTGGATTGTTCTCC 899-923 nt
bEcoRV-f12 GCGATATCATGGAGAAGAAGTTGTTGT 649-675 nt Duplicate
bEcoRI-r12 CCGAATTCTCTTTCACTTTTATAGGATG 1721-1748 nt
PCV1-NLS2 ClaI-f CAATCGATAACGCCTCCTTGGATACGTCATC 1694-1724 nt PCV1 ΔNLS
DNA clone BglII-r GGAGATCTTCAATTCCCGCCTTTCTAG 1566-1592 nt
BamH-F TAGGATCCCCGTGCCATTTTTCCTTC 1594-1619 nt PCV2 NLS
MspI-r CGTTACCGGAGAAGAAGACAC 1696-1716 nt
PCV2-NLS1 BalI-PCV2-F CCTTGGCCACGTCATATCTGAA 1720-1741 nt PCV2 ΔNLS
DNA clone BamH-PCV2-R GAAAAATGGGATCCTCAACACC 1594-1615 nt
BglII-PCV1-F TACAGATCTTTCGGCGCCA 1588-1606 nt PCV1 NLS
BalI-PCV1-R TATTGGCCAAGGAGGCGTTA 1701-1720 nt
a, Primers also used for amplification of duplicate in PCV2-NLS1 DNA clone construction.
b, Primers also used for amplification of duplicate in PCV1-NLS2 DNA clones construction.
c, The restriction enzyme sites were underlined.
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Page 3 of 10nt) for PCV1 and PCV1-NLS2 as well as primers F1397
(5’-TGGGTGATCGGGGAGCAGG-3’, 1397-1415 nt)
and R36 (5’-GCTGCCGAGGTGCTGCCGCT-3’, 17-36
nt) for PCV2 and PCV2-NLS1.
Recovery and in vitro viability evaluation of the progeny
viruses
In order to determine the viability and in vitro character-
istics of the progeny viruses, PK-15 cells at 80% conflu-
ence in 6-well plate were transfected with 20 μg of PCV1,
PCV2, PCV1-NLS2 and PCV2-NLS1 DNA clone, respec-
tively. Each well of cells was collected 5 days post-trans-
fection, frozen and thawed for three times. Subsequently,
the cell lysates were inoculated on fresh PK-15 cells in
T-25 flasks, incubated for five days and then serially pas-
saged for 26 times. At each passage, 2 ml of the sus-
pended cells from each progeny virus was collected for
titration according to the Reed-Muench method. Briefly,
each progeny virus stock was serially 10-fold diluted, and
each dilution was inoculated into 8 wells on fresh PK-15
A:  
B: 
ORF2   
Kpn  I        
EcoR  I     EcoR I 
Xba  I      
P C V 2          
DNA  clone     
PCV2  genome   
Duplication     
1420    1419  
1358   1745  
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DNA  clone     
PCV1 ORF2 NLS   
PCV2 ORF2s     
PCV2  ORF2s   
Kpn I      
pUC-18      
Kpn I    
EcoR  V    
EcoR   I       
PCV1 
DNA clone 
1759/1 
(3’/5’) 
916  915 
621  1740   Duplication       
      
PCV1-NLS2 
DNA clone 
PCV2 ORF2 NLS
PCV1  ORF2s    PCV1  ORF2s   
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Figure 1 Schematic construction of the infectious DNA clones. (A) The PCV1 DNA clone was constructed by ligating a duplicated fragment
(915-1740 nt) to the Kpn I-digested PCV1 genome in pUC-18. The chimeric PCV1-NLS2 DNA clone was constructed replacing the ORF2 NLS
sequence in PCV1 genomic backbone with NLS of PCV2 ORF2. (B) The PCV2 DNA clone was constructed by ligating a fragment (1419-1745 bp)
to the EcoR I-digested PCV2 genome in pUC-18. The chimeric PCV2-NLS1 was constructed by replacing the PCV2 ORF2 NLS with PCV1 ORF2
NLS. The partial duplications were indicated by dashed. Positions of primers and the directions of ORF were marked by arrows and the
orientations of the triangles, respectively.
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Page 4 of 10cells seeded on 48-well plates. Mock-inoculated cells
were incubated as negative controls. The virus- or mock-
infected cells were fixed at 3 days post-inoculation and
t h e5 0 %t i s s u ec u l t u r ei n f e c t i v ed o s e( T C I D 50)p e rm lo f
progeny viruses were determined by IFA as described
above and calculated by Reed-Muench method.
In vitro growth characteristics of PCV1, PCV2, PCV1-NLS2
and PCV2-NLS1 viruses
Twelve-well plates were seeded of PK-15 cells free of PCV
at 5 × 10
5 cells per well. When the cells were 80% conflu-
ent, sixteen wells of cells for each progeny virus were
inoculated with PCV1, PCV2, PCV1-NLS2 and PCV2-
NLS1 viruses at a multiplicity of infection (MOI) of 0.1,
respectively. After incubation for 1 hour, the inoculum
was discarded, and the cells were maintained in MEM
with 2% fetal bovine serum. Two wells of cells inoculated
with each virus were harvested at intervals of 12 hours
and stored until titration, virus quantification and western
blot analysis. Finally, the infectious titers of progeny
viruses at different time points were determined by IFA as
described above. And the genomic copy numbers of
viruses in cells were quantified by a TaqMan-based real
time PCR. Shortly, viral DNA was extracted using the
QIAamp DNA Mini kit (QIAGEN) from cells harvested
according to the manufacturer’s instruction. Genomic
DNA copy numbers for each virus at different time points
were determined using PCV1 or PCV2 ORF2-based pri-
mer pairs and probes (Table 2) on LightCycler
® 480
(Roche, Germany) under conditions: 3 min at 50°C, 5 min
at 94°C, followed by 40 cycles of 10 s at 94°C and 45 s at
60°C. Ten-fold serially diluted pUC-PCV1 and pIS-PCV2
plasmids were included to generate a standard curve.
Western bolt analysis was conducted to confirm the
evidence and kinetics of viral capsid protein expression at
different time points. The cells were sedimented by cen-
trifugation and lysed, the proteins were separated by
SDS-PAGE and transferred onto nitrocellulose mem-
branes (Pall Co. Ltd., USA) in Semi-dry transfer cell (Bio-
Rad) at 20 V for 45 minutes. The membranes were then
blocked with 5% (w/v) skim milk diluted in PBS-T for 2
hours at 37°C. After washing, the membranes were
probed with PCV1 or PCV2 capsid protein specific
polyclonal antibodies (1:250 dilution) for 1 hour, followed
by incubation with horseradish peroxidase conjugated
goat IgG (KPL Inc., USA) for 45 minutes. Finally, signals
were developed with 4-chloro-1-naphthol and examined.
Results
The DNA clones were infectious in transfected PK-15 cells
and generated infectious progeny viruses in vitro
PCV1 or PCV2 DNA clone was constructed by ligating a
duplicated fragment to the 3’ end of respective genome
cloned in the pUC-18 vector (Figure 1). Evaluated by IFA
two days after transfection, presence of PCV1- or PCV2
capsid protein was observed in approximately 15-20% of
the transfected cells (Figure 2A and 2C), whereas the
mock-transfected cells with pUC-18 vector remained
negative, indicating that the PCV1 and PCV2 DNA
clones were infectious in vitro (Figure 2E and 2F).
The PCV1-NLS2 DNA clone contained a chimeric
PCV1-NLS2 genome in which NLS sequence of PCV1
ORF2 was replaced by that of PCV2. IFA with PCV1 anti-
bodies confirmed that 10% of the cells were transfected
(Figure 2B), showing that the PCV1-NLS2 chimeric DNA
clone could replicate in vitro and express chimeric capsid
protein with PCV1 ORF2 NLS motifs, as predicted.
In contrast, the reciprocal PCV2-NLS1 DNA clone
contained a chimeric PCV2-NLS1 genome in which
PCV2 ORF2 NLS sequence was replaced by that of
PCV1. The presence of chimeric capsid protein detected
in approximately 10% of transfected cells (Figure 2D)
indicated that PCV2-NLS1 DNA clone was infectious in
vitro and encode chimeric capsid protein with PCV1
ORF2 NLS motifs.
Two primer pairs were introduced to monitor and dis-
tinguish the genomic viral DNA produced in transfected
cells from the input plasmid DNA. As a result, primers
R63 and F894 amplified a fragment of 928 bp which
could only be the product from circular genomes of
PCV1 or PCV1-NLS2. Moreover, primers F1397 and R36
amplified a 407 bp fragment, which was indicative of the
presence of the PCV2 or PCV2-NLS1 viral genome.
However, the 4400 bp or 3400 product from the input
plasmid DNA was not observed (data not shown). The
findings reflected that the capsid proteins detected in
Table 2 Primers and probes designed for Real-time PCR
Primer Sequence (5’-3’) Primer location Targeting
Re-ORF22-F1 CGCTCTGTGCCCTTTGAATAC 1325-1347 nt
Re-ORF22-R1 GTGAGGGCTGTGGCCTTTGTTAC 1450-1470 nt PCV2 ORF2
PCV2-probe1 FAM-ATTCTGGCCCTGCTCCCCGAT-TAMRA 1403-1423 nt
Re-PCV1-F AGGTGATGGGGTCTCTG 1384-1400 nt PCV1 ORF2
Re-PCV1-R TACCCCTACCTTTCCAATACTAC 1433-1455 nt
PCV1-FAM FAM-ATTCATATTTAGCCTTTCTAAT-TAMRA 1408-1429 nt
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Page 5 of 10transfected cells were synthesized from viral genomes
which might be circularized as the result of homologous
recombination from DNA clones, rather than from the
input plasmid [28].
Confirmation of the viability and stability of progeny
viruses during serial passages
The transfected cell lysates were further inoculated onto
fresh PK-15 cells. The viral proteins observed in nucleus
of inoculated cells by IFA confirmed that the progeny vir-
ions produced by in vitro transfection were infectious. All
the homogeneous PCV1, PCV2, PCV1-NLS2 and PCV2-
NLS1 virus stocks originated from transfected cells had
low initial titers ranged from 10
2.6 to 10
3.7 TCID50/ml,
showing no significant difference with each other. How-
ever, all the four virus stocks gave rise to gradually
increasing infectious titers during passages and propa-
gated stably after 16 to 20 passages (Figure 3), indicating
that the DNA clones were capable of producing infec-
tious and viable virions in vitro. The infectious titers of
P C V 1a n dP C V 2m a i n t a i n e da ta b o u t1 0
5.6 and 10
5.0
TCID50/ml respectively, which were significantly higher
A  B 
C  D  
E  F 
Figure 2 The DNA clones were infectious when transfected in PK-15 cells in vitro. The cells were stained with polyclonal antibody to the
PCV1 (A and B) or PCV2 (C and D) capsid protein. (A) PK-15 cells transfected with PCV1 DNA clone. (B) PK-15 cells transfected with chimeric
PCV1-NLS2 DNA clone. (C) PK-15 cells transfected with PCV2 DNA clone. (D) PK-15 cells transfected with chimeric PCV2-NLS1 DNA clone. (E and
F) Mock-transfected PK-15 cells with pUC-18.
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Page 6 of 10than that of chimeric PCV1-NLS2 and PCV2-NLS1 (10
4.2
and 10
3.8 TCID50/ml) after adaptation in vitro (P < 0.05).
However, PCV2-NLS1 had much lower titer than did
PCV1-NLS1 (P<0 . 0 5 ), which was consistent with the
finding that wild type PCV1 showed statistically higher
titer than did PCV2.
T h eg e n o m es e q u e n c eo fp r o g e n yv i r u s e sw e r em o n i -
tored by genomic sequencing during the passages. The
results showed that all the progeny viruses were geneti-
cally stable in PK-15 cells for passages, as no additional
mutation or reversion was found in the genomes (data
not shown). The findings indicated that the nuclear
localization signal sequence of ORF2 was functionally
exchangeable between PCV1 and PCV2.
In vitro growth characteristics of PCV1, PCV2, PCV1-NLS2
and PCV2-NLS1 viruses
To further confirm the growth characteristics of the pro-
geny viruses in vitro, one-step growth curve was per-
formed for each virus. Cells inoculated with each virus at
an MOI of 0.1 were collected at intervals of 12 hours.
The titers for each virus at different time points were
determined by IFA. PCV1, PCV2, PCV1-NLS2 and
PCV2-NLS1 all gave rise to similar numbers of viruses
after initial infection, since the initial infectious titers
were all less than 10
1.8 TCID50/ml (Figure 4). However,
the infectious titers for all viruses gradually increased
from 12 to 96 hours. PCV1 propagated most efficiently in
vitro and had a significantly higher titer of 10
4.3 TCID50/
ml by 96 h post-infection, whereas the infectious titer of
PCV2 was 10
3.6 TCID50/ml. With regard to the two chi-
meric viruses, PCV1-NLS2 gave better growth perfor-
mance than PCV2-NLS1, as they had the infectious titers
of about 10
3.35 and 10
3.0 TCID50/ml by 96 hour post
infection, respectively. The results were further con-
firmed by real time PCR with the findings which showed
0.7 to 1 log of increasing genomic copy number of all the
four viruses during the infection (Figure 5A). In spite of
the similar copy numbers of genomic DNA after initial
infection for all viruses, PCV1 genomic DNA was
detected as about 1.6 × 10
8 copies/ml by 96 hour post
infection, which was statistically higher than that of the
other viruses. Moreover, PCV1-NLS2 replicated more
efficiently in vitro, as compared with PCV2-NLS1.
Kinetics of capsid protein biosynthesis of the progeny
viruses were then determined by western blotting with
specific antibodies to PCV1 or PCV2 capsid protein. As
showed in Figure 5B, expression of capsid protein from
PCV1 infected cells were observed from 36 h post infec-
tion, whereas PCV2 capsid protein were detected from
48 h post infection. However, capsid protein of PCV2-
NLS1 and PCV1-NLS2 were detected later until 72 h
post infection, which would be due to the low level of
propagation efficiency of the chimeric viruses.
Discussion
PMWS has become one of the most economically impor-
tant and complex disease syndromes in the global swine
industry today. Although the etiology and pathogenesis
of PMWS appear to be complicated since other viral or
non-viral agents are considered as co-factors [29-31],
increasing evidences suggest that PCV2 is the principal
causative agent [32-35]. Nevertheless, the limit of viral
replication efficiency in vitro and the lack of a biologically
pure form of virus stock have impeded the study of the
role of PCV2 in pathogenesis of PMWS [36]. However,
the use of infectious clone contributes to the research on
virus replication, pathogenesis and vaccine development
Figure 3 In vitro viability of progeny viruses after initial
transfection of PK-15 cells with DNA clones. Synchronized PK-15
cells were transfected with 20 μg of PCV1, PCV2, PCV1-NLS2 and
PCV2-NLS1 DNA clone followed by twenty-six serial passages. The
DNA clones were capable of producing infectious and viable virions
in vitro, and all the progeny viruses gave rise to gradually increasing
infectious titers during passages and propagated stably after 16 to
20 passages. The infectious titers were determined at each passage
according to the Reed-Muench method.
Figure 4 One-step growth curve of PCV1, PCV2, PCV1-NLS2
and PCV2-NLS1 viruses. Synchronized PK-15 cells were infected
with viruses all at an MOI of 0.1. The infectious titers for all viruses
were similarly lower than 10
1.8 TCID50/ml after initial infection, but
gradually increased from 12 to 96 hours. PCV1 propagated much
more efficiently in vitro with a significantly higher titer of 10
4.3
TCID50/ml by 96 h post-infection. The infectious titers of viruses
were determined by IFA with Reed-Muench method.
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Page 7 of 10by modification at molecular level and offers an opportu-
nity for availability of biologically pure virus stock
[28,37]. In this study, we described the constructions of
four different infectious clones based on PCV1 derived
from contaminated PK-15 cells and PCV2 strain isolated
from PMWS-affected piglets from China. The conse-
quent biologically pure progeny virus stocks were then
generated by transfection of PK-15 cells with those DNA
clones, followed by analysis of in vitro characteristics of
the progeny viruses.
It is reported that homologous recombination may
take place when identical or similar sequences are pre-
s e n ti no n em o l e c u l e[ 3 8 ] .T h u s ,a l lt h eP C V 1 ,P C V 2 ,
PCV2-NLS1 and PCV1-NLS2 DNA clone constructed in
this work contained a copy of respective genome ligated
in tandem with a partial duplication that enabled the
genome to circularize out of the recombinant plasmid
by homologous recombination and initiate viral replica-
tion. The DNA clones were all found to be infectious in
vitro when the plasmids were applied onto PK-15 cells,
since viral antigen were expressed in 10-20% of the
transfected cells. Moreover, a discriminative PCR ampli-
fied indicative fragments of the presence of viral gen-
omes, while no input plasmid DNA was detected. Taken
together, the findings confirmed that the PCV1, PCV2,
PCV2-NLS1 and PCV1-NLS2 viral genome were func-
tionally produced due to homologous recombination
from DNA clones, replicated and further synthesized
the viral antigen in vitro. After passages, biologically
pure and viable progeny viruses were successfully gener-
ated for further in vitro or in vivo studies. And the
strategy for construction of DNA clone was useful for
research on PCV replication, pathogenesis and vaccine
development.
It has been shown for geminiviruses that disruption of
coat protein synthesis or loss of its nuclear localization
resulted in a drastic reduction in single-stranded genomic
DNA accumulation [20,21,39]. PCV2 capsid protein is
expressed late in the infection cycle and co-located in
nucleoplasm together with replication (Rep) protein [22].
Thus, the coat protein may play a role in replication con-
trol and might be expected to influence early events
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B   
P C V 1       
PCV2-NLS1 
PCV1-NLS2   
28kD   
P C V 2       
A   
Figure 5 Synchronized PK-15 cells were infected with viruses all at an MOI of 0.1. (A)The virus loads for PCV1, PCV2, PCV1-NLS2 and PCV2-
NLS1 in cell cultures at each time point were determined by real-time PCR based on PCV1 or PCV2 ORF2 gene. (B) Kinetics of viral capsid
protein (28 kD) biosynthesis of progeny viruses from infected PK-15 cells at different time points were confirmed by western blot analysis with
polyclonal antibodies to PCV1 or PCV2 capsid protein.
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Previous studies have revealed that the nuclear accumu-
lation of PCV1 and PCV2 capsid protein are properly
mediated by their distinct NLS motifs [25,26]. Hence, we
questioned that whether the NLS of PCV ORF2 would
play an accessory role in viral replication due to its con-
tribution to nuclear accumulation of capsid protein. In
this study, both the chimeric capsid protein of PCV1-
NLS2, PCV2-NLS1 were visualized in the nucleus of the
transfected PK-15 cells, similarly to that of the wild type
PCV1 and PCV2. Taken together with the recovery of
infectious and genetically stable virions, the results indi-
cated that the nuclear localization signal sequence of cap-
sid protein was functionally exchangeable between PCV1
and PCV2 with respect to the role in nuclear importing
and viral propagation. Moreover, the infectious titres and
the replication efficiency of chimeric PCV1-NLS2 and
PCV2-NLS1 were much lower than that of wild type
PCV1 and PCV2 after passages for adaptation in vitro,
which indicated that ORF2 NLS played an accessory role
in the replication of PCV. However, when the ORF2 NLS
exchanged, the mutant PCV2 still replicated less effi-
ciently and showed lower infectious titre than did PCV1
mutant, as the same manner between wild type PCV1
and PCV2. The finding demonstrated that ORF2 NLS
was not responsible for the distinction of in vitro growth
characteristics between PCV1 and PCV2.
Previous studies have described the in vivo pathogeni-
city of the molecular PCV2 DNA clone of USA strain
and European strain [28,40]. Although differences in
pathogenicity among PCV2 isolates from PMWS cases
have not been clearly elucidated, numbers of substitu-
tions in PCV2 isolates from China have been described
[27]. Thus, further study will be carried out to demon-
strate the in vivo viral replication, immunogenicity and
pathogenicity of the DNA clones of Chinese PCV2b iso-
late and its NLS chimeric viruses.
Conclusions
The findings in this work confirmed that the DNA clones
were infectious in vitro and were capable of producing
infectious, biologically pure and genetically stable virions
which was useful for further research on PCV replication,
pathogenesis and vaccine development. The recovery of
the PCV1-NLS2 and PCV2-NLS1 progeny viruses also
indicated that the nuclear localization signal sequence of
capsid protein was functionally exchangeable between
PCV1 and PCV2 with respect to the role in nuclear
importing and viral propagation. The infectious titres
and the replication efficien c yo fc h i m e r i cP C V 1 - N L S 2
and PCV2-NLS1 were much lower than that of wild type
PCV1 and PCV2 after passages for adaptation in vitro,
indicating that ORF2 NLS play an accessory role in the
replication of PCV. Interestingly, the findings also
demonstrated that ORF2 NLS was not responsible for
the distinction of in vitro growth characteristics between
PCV1 and PCV2.
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